These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10223957)

  • 1. Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.
    Wu SW; Dornbusch K; Kronvall G
    Antimicrob Agents Chemother; 1999 May; 43(5):1294-7. PubMed ID: 10223957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.
    Fournier B; Roy PH; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1996 Feb; 40(2):454-9. PubMed ID: 8834897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.
    Liu Y; Mee BJ; Mulgrave L
    J Clin Microbiol; 1997 Sep; 35(9):2365-9. PubMed ID: 9276417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.
    Fournier B; Lu CY; Lagrange PH; Krishnamoorthy R; Philippon A
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1365-8. PubMed ID: 7574532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca.
    Fournier B; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1996 Feb; 40(2):460-3. PubMed ID: 8834898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
    Izdebski R; Fiett J; Urbanowicz P; Baraniak A; Derde LP; Bonten MJ; Carmeli Y; Goossens H; Hryniewicz W; Brun-Buisson C; Brisse S; Gniadkowski M; ;
    J Antimicrob Chemother; 2015 Dec; 70(12):3230-7. PubMed ID: 26318191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase.
    Jeong SH; Kim WM; Chang CL; Kim JM; Lee K; Chong Y; Hwang HY; Baek YW; Chung HK; Woo IG; Ku JY
    J Hosp Infect; 2001 Aug; 48(4):281-8. PubMed ID: 11461129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime.
    Wu SW; Dornbusch K; Göransson E; Ransjö U; Kronvall G
    J Antimicrob Chemother; 1991 Sep; 28(3):389-97. PubMed ID: 1960120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan.
    Sato T; Hara T; Horiyama T; Kanazawa S; Yamaguchi T; Maki H
    J Med Microbiol; 2015 May; 64(Pt 5):538-543. PubMed ID: 25813819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity.
    Nijhuis RH; Oueslati S; Zhou K; Bosboom RW; Rossen JW; Naas T
    J Antimicrob Chemother; 2015 May; 70(5):1429-33. PubMed ID: 25630648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
    Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
    PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
    Kimura K; Arakawa Y; Ohsuka S; Ito H; Suzuki K; Kurokawa H; Kato N; Ohta M
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1988-94. PubMed ID: 8878568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase.
    Fournier B; Arlet G; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1994 Feb; 116(1):31-6. PubMed ID: 8132152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance.
    Arstila T; Auvinen H; Huovinen P
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):468-74. PubMed ID: 7957266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.
    Fournier B; Roy PH
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1641-8. PubMed ID: 9257734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and amino acid sequence of the OXY-2 group beta-lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60.
    Farzaneh S; Péduzzi J; Sofer L; Reynaud A; Barthélémy M; Labia R
    J Antimicrob Chemother; 1997 Dec; 40(6):789-95. PubMed ID: 9462429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors.
    Fournier B; Lagrange PH; Philippon A
    J Antimicrob Chemother; 1996 May; 37(5):931-42. PubMed ID: 8737143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca.
    Fournier B; Gravel A; Hooper DC; Roy PH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):850-5. PubMed ID: 10103190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.